FDA Approves Pembrolizumab for Hodgkin Lymphoma

The FDA approved pembrolizumab for the treatment of some adult and pediatric patients with classical Hodgkin lymphoma.

from Cancer via ola Kala on Inoreader http://ift.tt/2paKjv1
via IFTTT